Nexium Buyers Call Drug Cos. 'Serial' Antitrust Violators
Nexium purchasers on Thursday defended their bid for an injunction against Ranbaxy Inc. and AstraZeneca PLC despite losing a recent pay-for-delay trial over the heartburn drug, arguing that the companies are...To view the full article, register now.
Already a subscriber? Click here to view full article